According to Masimo's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 54.8227. At the end of 2022 the company had a P/E ratio of 55.2.
Year | P/E ratio | Change |
---|---|---|
2022 | 55.2 | -21.56% |
2021 | 70.4 | 15.39% |
2020 | 61.0 | 42.01% |
2019 | 43.0 | 47.61% |
2018 | 29.1 | -11.13% |
2017 | 32.7 | 193.41% |
2016 | 11.2 | -56.18% |
2015 | 25.5 | 29.55% |
2014 | 19.7 | -30.73% |
2013 | 28.4 | 45.88% |
2012 | 19.5 | 11.37% |
2011 | 17.5 | -24.89% |
2010 | 23.3 | -28.9% |
2009 | 32.7 | -37.5% |
2008 | 52.3 | -7.73% |
2007 | 56.7 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 38.9 | -28.99% | ๐บ๐ธ USA |
General Electric GE | 18.8 | -65.63% | ๐บ๐ธ USA |
ResMed RMD | 35.7 | -34.86% | ๐บ๐ธ USA |
Cardinal Health CAH | 97.7 | 78.25% | ๐บ๐ธ USA |
Universal Forest Products
UFPI | 13.8 | -74.86% | ๐บ๐ธ USA |
CONMED CNMD | 39.7 | -27.52% | ๐บ๐ธ USA |
Owens & Minor
OMI | -14.8 | -127.02% | ๐บ๐ธ USA |
Philips PHG | -38.5 | -170.22% | ๐ณ๐ฑ Netherlands |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.